logo
Select company
Select metric
$ -3.87MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
37
Sector
41
Industry
44
History
13
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -3.87M
3/31/2025$ 1.76M
12/31/2024$ 6.12M
9/30/2024$ 5.15M
6/30/2024$ 5.3M
3/31/2024$ 1.43M
12/31/2023$ -2.58M
9/30/2023$ -4.46M
6/30/2023$ -3.89M
3/31/2023$ -5.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 8.6K.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average CF - Chg. Cash has been $ 1.01M.
  • The median CF - Chg. Cash for LEXARIA BIOSCIENCE CORP during this period was $ -399.69K
  • LEXARIA BIOSCIENCE CORP reached its highest CF - Chg. Cash over the past 5 years at $ 9.62M.
  • The lowest CF - Chg. Cash recorded by LEXARIA BIOSCIENCE CORP in the same timeframe $ -5.15M

LEXARIA BIOSCIENCE CORP's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
BRTX : BIORESTORATIVE THERAPIES INC $ -697KIBIO : IBIO INC $ -5.63MERNA : ERNEXA THERAPEUTICS INC $ -2.37MICU : SEASTAR MEDICAL HOLDING CORP $ 5.12MRLYB : RALLYBIO CORP $ -7.23MLYRA : LYRA THERAPEUTICS INC $ -2.12MPULM : PULMATRIX INC $ -8.02MVYNE : VYNE THERAPEUTICS INC $ -7.61MAPRE : APREA THERAPEUTICS INC $ -12.17MMGRX : MANGOCEUTICALS INC $ -388.36K

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

LEXX - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -5.15M

Minimum

Dec 31, 2022

$ 9.62M

Maximum

Sep 30, 2021

$ 1.01M

Average

$ -399.69K

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M